#cancersm Transcript
Healthcare social media transcript of the #cancersm hashtag.
– ().
See #cancersm Influencers/Analytics.
Sign up for FREE Symplur Account and Get
- Create Transcripts with Custom Dates
- Get Custom Influencer Lists
- 3x Hashtag Search Results
| Profile | Tweet |
|---|---|
 | Timothy Craig Allen @TimAllenMDJD Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectives from our own cancer communities. Our topic is “Basics of Biomarker Testing” |
 | Christina Lizaso @btrfly12 RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | #LCSM Chat @lcsmchat RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | Faces of Lung Cancer @LungCancerFaces RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | Jamie Holloway, PhD @jamienholloway Ready for tonight's chat: Basics of Biomarker Testing! #cancersm |
 | Liz Salmi @TheLizArmy RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
| Timothy Craig Allen @TimAllenMDJD I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology at the University of Mississippi Medical Center @UMMCnews @UMMC_Pathology in Jackson, Mississippi #cancersm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher #Myeloma peeps join in tonight's #cancersm chat #MMSM |
 | Bob Steele @steele_bob Good evening folks. Bob here from Greensboro, NC. #cancersm |
| Timothy Craig Allen @TimAllenMDJD More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology a… |
| Matthew Katz, MD @subatomicdoc RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw |
 | Shiela Appavoo @ShielaAppavoo RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | Ken @TheDura01 RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
| Bob Steele @steele_bob RT @LungCancerFaces: Remember #LCSM friends, for tonight’s chat we will use the #CANCERSM hashtag! https://t.co/pesMIAior5 |
| Timothy Craig Allen @TimAllenMDJD Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Twitter, or need a refresher, please read the #LCSM primer on participating in a Twitter chat -https://t.co/shziI4sXdT |
| Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology a… |
| Timothy Craig Allen @TimAllenMDJD We'll get started in a few minutes -- please take a moment to introduce yourselves. #cancersm |
 | Darcy Burbage @DarcyBurbage RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
 | Janet Freeman-Daily @JFreemanDaily Hi everyone! Welcome to the pancancer #CANCERSM chat on "Basics of Biomarkers Testing"! Remember to us #cancersm instead of other cancer hashtags (like #LCSM #BCSM #BTSM @GYCSM etc.) |
| #LCSM Chat @lcsmchat Deana Hendrickson @LungCancerFaces in Los Angeles here. Calling all #lcsm lung cancer people to tonight’s #CANCERSM Chat on biomarkers. |
 | Israh (K.)Akhtar @israhkhan RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
 | Betsy @wildwestannie Hello all! Betsy from Gloucester, MA here #cancersm |
| Bob Steele @steele_bob RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
| Timothy Craig Allen @TimAllenMDJD RT @LungCancerFaces: Remember #LCSM friends, for tonight’s chat we will use the #CANCERSM hashtag! https://t.co/pesMIAior5 |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
| Matthew Katz, MD @subatomicdoc Good evening, Matt Katz, radiation oncologist joining from Massachusetts. I hope everyone is well, looking forward to #cancersm |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Tw… |
| Janet Freeman-Daily @JFreemanDaily RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology a… |
| Jamie Holloway, PhD @jamienholloway I'm Jamie-- cancer scientist and advocate in the DC area. #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Please remember to include #cancersm in ALL your tweets so the other chat participants can see them. If you are new to Tw… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We'll get started in a few minutes -- please take a moment to introduce yourselves. #cancersm |
| Janet Freeman-Daily @JFreemanDaily RT @MyelomaTeacher: #Myeloma peeps join in tonight's #cancersm chat #MMSM https://t.co/sJiZO9lR1s |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: Hi everyone! Welcome to the pancancer #CANCERSM chat on "Basics of Biomarkers Testing"! Remember to us #cancersm instea… |
 | National Cancer Institute @theNCI The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
 | Pub Health Monitor @monitor_PH RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher Cindy - from NJ living with multiple myeloma #cancersm |
| Timothy Craig Allen @TimAllenMDJD If you prefer just to listen, please tweet "#cancersm” so we know you’re in the audience (but I urge you ahead and join in! |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/qcE5TUfeLp |
 | Alicia C. Staley @stales RT @TimAllenMDJD: More info about #cancersm and our topic “Basics of Biomarker Testing” can be found at https://t.co/FaMTn7FjgF |
| Timothy Craig Allen @TimAllenMDJD Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online resources. |
| #LCSM Chat @lcsmchat RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
| Alicia C. Staley @stales RT @TimAllenMDJD: If you prefer just to listen, please tweet "#cancersm” so we know you’re in the audience #cancersm |
| Timothy Craig Allen @TimAllenMDJD If you change someone’s words when you retweet, please label it MT (modified tweet). #cancersm |
 | P. F. Anderson @pfanderson RT @jamienholloway: Ready for tonight's chat: Basics of Biomarker Testing! #cancersm https://t.co/AoqVfpTcZw |
| Christina Lizaso @btrfly12 Hi All - I'm passionate about community engagement and cancer. Co-founder w/ @womenofteal of #gyncsm for gynecologic cancers. Love it when the cancer communities collaborate. #cancersm |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: I’m your moderator, Tim Allen (@timallenmdjd) Pulmonary pathologist. Professor and Chair of the Department of Pathology a… |
| Janet Freeman-Daily @JFreemanDaily RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
| Alicia C. Staley @stales RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat |
| Israh (K.)Akhtar @israhkhan Learn more about cancer, @ #CANCERSM |
| Alicia C. Staley @stales @theNCI Hi there! #cancersm |
 | Matthew Steliga MD @SteligaMD Hello, #cancersm- following along from Little Rock. |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online res… |
 | BTSM chat | #btsm @BTSMchat Hello #BTSM community: The #cancersm chat is happening RIGHT NOW. Use #cancersm in all of your tweets to join the discussion about the basics of biomarker testing! Do you know YOUR biomarkers?! |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: If you change someone’s words when you retweet, please label it MT (modified tweet). #cancersm |
| Timothy Craig Allen @TimAllenMDJD Note: Twitter allows tweets up to 280 characters, but some tweetchat apps (like https://t.co/9aLQySh2dV) will not display tweets longer than 140. #cancersm |
| Jamie Holloway, PhD @jamienholloway @lcsmchat Thx! Glad to join this pancancer chat! Thx for hosting! #cancersm |
| P. F. Anderson @pfanderson Grateful for the invite to #CANCERSM (and that I finally got it on my calendar in the right place!) Excited to learn and share about biomarkers. |
| Liz Salmi @TheLizArmy RT @BTSMchat: Hello #BTSM community: The #cancersm chat is happening RIGHT NOW. Use #cancersm in all of your tweets to join the discussio… |
| Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online res… |
| Matthew Katz, MD @subatomicdoc RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
 | Peggy Dennis @peggyddennis Hello! Following from Denver #cancersm |
| Timothy Craig Allen @TimAllenMDJD Glad to see #cancersm Twitter handles participating tonight! #GoTeam |
| Alicia C. Staley @stales Hey #BCSM crew: The #cancersm chat is happening now! |
| Janet Freeman-Daily @JFreemanDaily Janet Freeman-Daily in Seattle here--writer, science geek, lung cancer patient research advocate (https://t.co/OBCc87ZwkG) #CANCERSM |
| P. F. Anderson @pfanderson RT @btrfly12: Hi All - I'm passionate about community engagement and cancer. Co-founder w/ @womenofteal of #gyncsm for gynecologic cancers.… |
 | LungCancer.net @LungCancer_HU Margot here! #cancersm |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online res… |
| Matthew Steliga MD @SteligaMD RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
| Timothy Craig Allen @TimAllenMDJD I will announce FIVE topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #cancersm |
| Alicia C. Staley @stales I'm Alicia - Co-founder of #BCSM. 3x cancer survivor - Thanks for hosting tonight's chat! #cancersm |
| Janet Freeman-Daily @JFreemanDaily RT @TimAllenMDJD: Please do not promote products or services on the #cancersm feed or during the chat. Feel free to share vetted online res… |
| Bob Steele @steele_bob Wife & I are both cancer survivors (breast, melanoma) but lung cancer advocates in honor of my dad who passed at young age of 58. #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Note: Twitter allows tweets up to 280 characters, but some tweetchat apps (like https://t.co/9aLQySh2dV) will not display… |
| Alicia C. Staley @stales @lcsmchat @theNCI Hello, hello! #CancerSM |
| LungCancer.net @LungCancer_HU RT @LungCancerFaces: Remember #LCSM friends, for tonight’s chat we will use the #CANCERSM hashtag! https://t.co/pesMIAior5 |
| Timothy Craig Allen @TimAllenMDJD RT @steele_bob: Wife & I are both cancer survivors (breast, melanoma) but lung cancer advocates in honor of my dad who passed at young age… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Glad to see #cancersm Twitter handles participating tonight! #GoTeam |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: I will announce FIVE topics (T1 T2 etc). Pls label your answers with T1, T2, etc to make transcript easier to follow. #c… |
| Timothy Craig Allen @TimAllenMDJD We’ll start with Topic T1 in a minute … #cancersm |
| Darcy Burbage @DarcyBurbage Hi everyone! I’m Darcy oncology nurse from Delaware looking forward to tonight’s chat! #CANCERSM |
 | Amanda Narod @AmandaBinDC @JFreemanDaily @gycsm Awesome! Amanda in DC. Previvor brca2+ patient advocate & cancer communications professional. Lurking and following along. #cancersm. |
| Liz Salmi @TheLizArmy @TimAllenMDJD Liz here from the #BTSM/brain tumor social media community! I'm living with grade II astrocytoma and I have biomarkers! I am IDH-1 positive, ATRX negative. BOOM! Overshare. #cancersm https://t.co/aTlYGCLgKt |
| Israh (K.)Akhtar @israhkhan Good evening everyone, I am a Pathologist with expertise in cytopathology, breast,& pulmonary pathology #CANCERSM |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @theNCI Glad to see you here! #MMSM #cancersm |
 | Ashley Love Sumrall, MD, FACP @AshleySumrallMD Neuro-onc checking in for #btsm representation for #cancersm #biomarkers 🙌🏻 |
| Timothy Craig Allen @TimAllenMDJD T1: What is a biomarker and how is it identified? #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: We’ll start with Topic T1 in a minute … #cancersm |
 | Sarika Jain @drjainsp I am a molecular pathologist and a hematopathologist #cancersm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm |
| Amanda Narod @AmandaBinDC RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
| Liz Salmi @TheLizArmy @theNCI Nice to see @theNCI in the house! Tagging @NIHBrainTumor because they are the #BTSM homies. 😎 #cancersm |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm |
| P. F. Anderson @pfanderson @TimAllenMDJD Is this a quiz? Or a lecture? #CancerSM |
| Timothy Craig Allen @TimAllenMDJD T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat focuses specifically on molecular biomarkers of cancer. Molecular biomarkers of cancer are identified by pathologists using laboratory testing. #cancersm |
| National Cancer Institute @theNCI T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. https://t.co/uCNkV7yF4T #cancersm https://t.co/qxvO2FOQI0 |
| Pub Health Monitor @monitor_PH RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| Alicia C. Staley @stales RT @TimAllenMDJD: T1: What is a biomarker and how is it identified? #cancersm #cancersm |
| Janet Freeman-Daily @JFreemanDaily T1: Holding my breath waiting for all the pathologists to answer ... #CANCERSM |
 | Hillary Stires, PhD @HillStirSci I’m Hillary! A frequenter of #bcsm, past breast cancer research scientist, currently working in health care policy. #cancersm |
| #LCSM Chat @lcsmchat Both? #cancersm |
| Timothy Craig Allen @TimAllenMDJD It's a discussion! #cancersm |
| P. F. Anderson @pfanderson Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
 | Anna Vioral (Gavin) @AnnaVioral RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher T1- Someone tell me what a biomarker is! #MMSM #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: It's a discussion! #cancersm https://t.co/RJQhC9XOCD |
| P. F. Anderson @pfanderson NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| Darcy Burbage @DarcyBurbage RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| Bob Steele @steele_bob RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat foc… |
 | Henning Willers, MD @HenningWillers @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM |
| P. F. Anderson @pfanderson NCI Dictionary of Cancer Terms - biomarker https://t.co/rVcUwuvJ4d "A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease... Also called molecular marker and signature molecule." #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm |
| National Cancer Institute @theNCI T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule. #cancersm https://t.co/P7BJJJo98m |
| Christina Lizaso @btrfly12 RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| #LCSM Chat @lcsmchat RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| Pub Health Monitor @monitor_PH RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| #LCSM Chat @lcsmchat RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM |
| Bob Steele @steele_bob RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM |
| #LCSM Chat @lcsmchat RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm |
| Christina Lizaso @btrfly12 RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| P. F. Anderson @pfanderson FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM |
| #LCSM Chat @lcsmchat RT @pfanderson: NCI Dictionary of Cancer Terms - biomarker https://t.co/rVcUwuvJ4d "A biological molecule found in blood, other body fluids… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| Matthew Katz, MD @subatomicdoc RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: NCI Dictionary of Cancer Terms - biomarker https://t.co/rVcUwuvJ4d "A biological molecule found in blood, other body fluids… |
| National Cancer Institute @theNCI T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both normal and cancer cells but at higher amounts by cancer cells. https://t.co/km00Uh6EWM #cancersm |
| Pub Health Monitor @monitor_PH RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| P. F. Anderson @pfanderson FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat foc… |
| #LCSM Chat @lcsmchat RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM |
| Matthew Katz, MD @subatomicdoc RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| #LCSM Chat @lcsmchat RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| Bob Steele @steele_bob RT @HenningWillers: @theNCI T1 anything can be a biomarker. Does not have to be a molecule. #cancersm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher T1- Is fever is a biomarker of infection? #cancersm |
| Alicia C. Staley @stales RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM |
| #LCSM Chat @lcsmchat RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM |
| Liz Salmi @TheLizArmy RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T1: There are lots of “biomarkers” of cancer, e.g., obesity is a prognostic biomarker for certain cancers. This chat foc… |
| P. F. Anderson @pfanderson RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| Bob Steele @steele_bob RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/Ua6gPOZevl #CancerSM |
| Alicia C. Staley @stales RT @pfanderson: FDA: BIOMARKER TERMINOLOGY: SPEAKING THE SAME LANGUAGE https://t.co/7KTEDxPF7d #CancerSM |
| National Cancer Institute @theNCI T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted therapy, or whether it is responding to treatment: https://t.co/km00Uh6EWM #cancersm |
| Alicia C. Staley @stales RT @pfanderson: NIEHS: Biomarkers https://t.co/xadnCHehR1 #CancerSM |
| Pub Health Monitor @monitor_PH RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: T1- Is fever is a biomarker of infection? #cancersm |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: T1- Is fever is a biomarker of infection? #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @stales: RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM |
| #LCSM Chat @lcsmchat RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Matthew Katz, MD @subatomicdoc RT @stales: RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/GmeVQy9VGa #CancerSM |
| Christina Lizaso @btrfly12 RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| Alicia C. Staley @stales @MyelomaTeacher I"m learning tonight too! #cancersm |
| P. F. Anderson @pfanderson @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM |
 | Baby Bird @intanmika RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Timothy Craig Allen @TimAllenMDJD RT @stales: RT @pfanderson: NIEHS: Biomarkers https://t.co/xadnCHehR1 #CancerSM |
| Henning Willers, MD @HenningWillers T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok that was not really the question) #cancersm |
| Matthew Steliga MD @SteligaMD T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| Bob Steele @steele_bob RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM |
| P. F. Anderson @pfanderson RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| Sarika Jain @drjainsp T1: A Biomarker also tells you if you will respond to a treatment and also treatment response #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @stales: @MyelomaTeacher I"m learning tonight too! #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM |
| P. F. Anderson @pfanderson RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| Darcy Burbage @DarcyBurbage RT @pfanderson: FDA: What Are Biomarkers and Why Are They Important? Transcript https://t.co/Ndpiy1XWlp #CancerSM |
| Bob Steele @steele_bob RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| #LCSM Chat @lcsmchat RT @pfanderson: @lcsmchat LOL! I'm seeing great stuff being shared from a lot of different directions. Going to be a great hour! #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th… |
| #LCSM Chat @lcsmchat RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th… |
| #LCSM Chat @lcsmchat RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| Timothy Craig Allen @TimAllenMDJD RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| P. F. Anderson @pfanderson RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| #LCSM Chat @lcsmchat RT @drjainsp: T1: A Biomarker also tells you if you will respond to a treatment and also treatment response #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T1: A Biomarker also tells you if you will respond to a treatment and also treatment response #cancersm |
 | Liza Bernstein @itsthebunk I misread the announcement and am going to have to join the #cancersm chat late! |
| Amanda Narod @AmandaBinDC T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
| Darcy Burbage @DarcyBurbage RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th… |
| Liz Salmi @TheLizArmy @TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is removed or biopsied... ? #cancersm #btsm |
 | Uppity Cancer Pt @UppityCancerP RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| Israh (K.)Akhtar @israhkhan #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in ascitic fluid c) lung carcinoma invading blood vessel and Lung adenocarcinoma. What can we do to prevent it or are there any potential tests which can aid in Rx https://t.co/0C3ZOTqEO8 |
| Timothy Craig Allen @TimAllenMDJD RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
| Bob Steele @steele_bob RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is… |
| National Cancer Institute @theNCI T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict the effectiveness of treatment, and to predict the chance of cancer recurrence. #CancerSM |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher #cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296 |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti… |
| Pub Health Monitor @monitor_PH RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Liza Bernstein @itsthebunk About to drive. Will try to join in about 30 mins #cancersm |
| Bob Steele @steele_bob RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti… |
| Timothy Craig Allen @TimAllenMDJD T2: What is biomarker testing and what is it used for? #cancersm |
 | Luciole @Luciole0207 RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
 | Brenda Conaway @BLouConaway RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
 | Dee Sparacio @womenofteal Hi #CANCERSM friends, Sorry to be joining late. And trying to catch up. Dee here #gyncsm co-founder. |
| #LCSM Chat @lcsmchat RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
| Darcy Burbage @DarcyBurbage RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @TimAllenMDJD So I am guessing, for us brain tumor people, our biomarkers are found in the TISSUE of the tumor after it is… |
| Liz Salmi @TheLizArmy @theNCI Where's @xelamb and @GCAResearch at??? This biomarker stuff has to be your jam. #btsm #cancersm |
| Alicia C. Staley @stales RT @TimAllenMDJD: T2: What is biomarker testing and what is it used for? #cancersm #cancersm |
| #LCSM Chat @lcsmchat RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti… |
 | María Triolo Mieses @MariaTriolo RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| #LCSM Chat @lcsmchat RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Alicia C. Staley @stales @womenofteal hey there! #cancersm |
| Brenda Conaway @BLouConaway RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: #cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296 |
| Matthew Steliga MD @SteligaMD RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T2: What is biomarker testing and what is it used for? #cancersm |
| Alicia C. Staley @stales @TheLizArmy hey there #cancersm |
| Bob Steele @steele_bob RT @MyelomaTeacher: #cancersm This is a great slide. #MMSM #Biomarkers https://t.co/XvmjWfL296 |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
 | George Osei-Bonsu @GOseiBonsu RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Dee Sparacio @womenofteal #gyncsm |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @theNCI Where's @xelamb and @GCAResearch at??? This biomarker stuff has to be your jam. #btsm #cancersm |
| National Cancer Institute @theNCI T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissue markers. https://t.co/NfmRcRa1I1 #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @womenofteal: Hi #CANCERSM friends, Sorry to be joining late. And trying to catch up. Dee here #gyncsm co-founder. |
| Pub Health Monitor @monitor_PH RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| Sarika Jain @drjainsp T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| Dee Sparacio @womenofteal #gyncsm |
| Darcy Burbage @DarcyBurbage RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| Dee Sparacio @womenofteal #gyncsm |
| Timothy Craig Allen @TimAllenMDJD Welcome! #cancersm |
| Alicia C. Staley @stales RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| #LCSM Chat @lcsmchat RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| P. F. Anderson @pfanderson RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
| Bob Steele @steele_bob RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| #LCSM Chat @lcsmchat RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| National Cancer Institute @theNCI T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cancer, are used, for example, to estimate prognosis and to assess the response to treatment. #CancerSM |
| Dee Sparacio @womenofteal RT @stales: RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #can… |
| Timothy Craig Allen @TimAllenMDJD RT @stales: RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #can… |
| P. F. Anderson @pfanderson RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti… |
| Timothy Craig Allen @TimAllenMDJD T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a cancer cell for e.g. a protein, or the identification of mutations or other changes in the cancer cell genes. #cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| Pub Health Monitor @monitor_PH RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| Liz Salmi @TheLizArmy @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No longer do we talk about the types or grades (i.e. stage) of our tumors, we talk about our biomarkers. For reals. 🤓 #BTSM #cancersm |
| Uppity Cancer Pt @UppityCancerP RT @pfanderson: NIEHS: Biomarkers https://t.co/cNuwLouCPJ #CancerSM |
| Darcy Burbage @DarcyBurbage RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| National Cancer Institute @theNCI T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate prognosis, and to select an appropriate treatment (e.g., treatment with a targeted therapy). #cancersm |
| Jamie Holloway, PhD @jamienholloway T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis, or are predictive for response to treatment #CANCERSM |
| Christina Lizaso @btrfly12 RT @HenningWillers: T1 A biomarker can be predictive of treatment response or prognostic for disease course independent of treatment (ok th… |
| Uppity Cancer Pt @UppityCancerP RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| Pub Health Monitor @monitor_PH RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c… |
| Christina Lizaso @btrfly12 RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c… |
| Jamie Holloway, PhD @jamienholloway @TheLizArmy @HenningWillers We do that in the breast cancer world, too! #cancersm |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| Baby Bird @intanmika RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| #LCSM Chat @lcsmchat RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| Timothy Craig Allen @TimAllenMDJD This #cancersm |
 | CancerDotNet @CancerDotNet RT @AmandaBinDC: T1 lay friendly overview https://t.co/GnpK7bWJkm #cancersm @CancerDotNet |
 | Ginger Riley @gingerly21 RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
| National Cancer Institute @theNCI T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: https://t.co/km00Uh6EWM #cancersm |
| Pub Health Monitor @monitor_PH RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| Timothy Craig Allen @TimAllenMDJD RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| Henning Willers, MD @HenningWillers @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| Baby Bird @intanmika RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
 | Elite Health @ELITEHEALTHGR RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
 | Khadijah | خديجة @kfaziz RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| #LCSM Chat @lcsmchat RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| Timothy Craig Allen @TimAllenMDJD RT @jamienholloway: @TheLizArmy @HenningWillers We do that in the breast cancer world, too! #cancersm |
| Darcy Burbage @DarcyBurbage RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| Alicia C. Staley @stales RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| #LCSM Chat @lcsmchat RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| Dee Sparacio @womenofteal #gyncsm |
| Bob Steele @steele_bob RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| Sarika Jain @drjainsp T2 An example of a diagnostic biomarker is prostate-specific antigen (PSA) used for screening of prostate cancer. An example of a therapeutic biomarker is EGFR gene testing in patients with lung cancer.#cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| Matthew Katz, MD @subatomicdoc RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
 | 🇺🇸 Sal @SalJG1262 RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T2 An example of a diagnostic biomarker is prostate-specific antigen (PSA) used for screening of prostate cancer. An example… |
| P. F. Anderson @pfanderson @theNCI It has been an amazing ride the past couple decades, watching noninvasive biomarker testing emerge & become refined. First predicted in the early 1900s, and they made fun of the guy then. Now we have salivary & urinary & breath analysis #CancerSM |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gcDDoZ7Rqb |
| Darcy Burbage @DarcyBurbage RT @drjainsp: T2 An example of a diagnostic biomarker is prostate-specific antigen (PSA) used for screening of prostate cancer. An example… |
| #LCSM Chat @lcsmchat RT @drjainsp: T2 An example of a diagnostic biomarker is prostate-specific antigen (PSA) used for screening of prostate cancer. An example… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T2: What is biomarker testing and what is it used for? #cancersm |
| Uppity Cancer Pt @UppityCancerP Hey, all. Meet @stales. She is the health social media goddess from #bcsm and will keep all of us on track. You may borrow her for now. 😊 #cancersm |
| Liz Salmi @TheLizArmy @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor is more or less aggressive and likely to respond more favorably to various treatments. Treatment decisions are based on biomarkers. #btsm #cancersm |
 | Sarah Temkin @temkins RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc… |
| Christina Lizaso @btrfly12 RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| Dee Sparacio @womenofteal #gyncsm |
| Janet Freeman-Daily @JFreemanDaily @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural fluid often also contains tumor cells that can undergo biomarker testing. #LCSM #cancersm |
| P. F. Anderson @pfanderson RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @theNCI Would the measurement of my m-protien in my blood be considered a biomarker for myeloma ? #MMSM #CancerSM |
| Israh (K.)Akhtar @israhkhan #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need hormonal therapy or chemotherapy or Herceptin, more recently in April 2019, immunotherapy has been approved by FDA in triple negative breast ca patients https://t.co/qurV1a4y3i |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i… |
| Henning Willers, MD @HenningWillers @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm |
| P. F. Anderson @pfanderson RT @UppityCancerP: Hey, all. Meet @stales. She is the health social media goddess from #bcsm and will keep all of us on track. You may borr… |
| P. F. Anderson @pfanderson RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: @theNCI Would the measurement of my m-protien in my blood be considered a biomarker for myeloma ? #MMSM #CancerSM |
 | OPensador89 @OPensador89 RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| Bob Steele @steele_bob RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc… |
| Timothy Craig Allen @TimAllenMDJD Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm |
| #LCSM Chat @lcsmchat RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Darcy Burbage @DarcyBurbage RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: @theNCI Would the measurement of my m-protien in my blood be considered a biomarker for myeloma ? #MMSM #CancerSM |
| #LCSM Chat @lcsmchat RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L |
| P. F. Anderson @pfanderson Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteomics: future diagnostic and clinical utilities https://t.co/Epp0cUOsdq #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @UppityCancerP: Hey, all. Meet @stales. She is the health social media goddess from #bcsm and will keep all of us on track. You may borr… |
 | Merrilee Fullerton, MPP @DrFullertonMPP RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| P. F. Anderson @pfanderson RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Bob Steele @steele_bob RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm |
| Merrilee Fullerton, MPP @DrFullertonMPP RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| Sarika Jain @drjainsp RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Merrilee Fullerton, MPP @DrFullertonMPP RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteo… |
 | Jose Hernandez @Pharma_Mty RT @theNCI: T1 A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal pr… |
 | Noel12.1 @noel12_1 RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Matthew Katz, MD @subatomicdoc RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
 | Dennis Keim @denniskeim RT @pfanderson: Kyle Strimbu and Jorge A. Tavel, M.D. What are Biomarkers? (2011) https://t.co/CV1ROepZnS #CancerSM |
| Jose Hernandez @Pharma_Mty RT @theNCI: T1 Tumor markers, which are a type of biomarker, have traditionally been proteins or other substances that are made by both nor… |
| Janet Freeman-Daily @JFreemanDaily Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM #cancersm |
| Jose Hernandez @Pharma_Mty RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| National Cancer Institute @theNCI RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T1 Cancer researchers are working to develop new biomarkers that can be used to identify cancer in its early stages, to predict… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| National Cancer Institute @theNCI RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i… |
| #LCSM Chat @lcsmchat RT @pfanderson: Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteo… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Jose Hernandez @Pharma_Mty RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Darcy Burbage @DarcyBurbage RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Dennis Keim @denniskeim RT @SteligaMD: T1 basic info on Wikipedia: https://t.co/CfEcQ77LCv. #cancersm https://t.co/4TWuSniPGP |
| Liz Salmi @TheLizArmy @TimAllenMDJD In 2016 @WHO released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge about biomarkers. This new classification system kind of rocked the brain tumor world and it was really exciting for the #neuropath community. #btsm #cancersm |
| National Cancer Institute @theNCI RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
 | Deb Smith 🍀 @debsmithbeach Deb from NH here, sorry to be late. #cancersm |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @TimAllenMDJD In 2016 @WHO released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge… |
| National Cancer Institute @theNCI RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cancersm |
 | Vin :-) @vincruze RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @TimAllenMDJD In 2016 @WHO released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge… |
 | هيوني فهد. @HIONE55 RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Dee Sparacio @womenofteal @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM |
| P. F. Anderson @pfanderson @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening (2015) https://t.co/ccpsi93wS2 #CancerSM |
| Alicia C. Staley @stales RT @UppityCancerP: Hey, all. Meet @stales. She is the health social media goddess from #bcsm and will keep all of us on track. You may borr… |
| Dee Sparacio @womenofteal RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
 | 🏳️🌈🏳️🌈Vinny502🏳️🌈🏳️🌈 @VMendez502 RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| Liz Salmi @TheLizArmy @AshleySumrallMD @HenningWillers Yes! I just tweeted that! LOL Use #cancersm for tonight's chat. ;) |
| Dennis Keim @denniskeim RT @drjainsp: T2 Molecular biomarker tests are generally of three types of biomarkers: diagnostic, therapeutic, prognostic #cancersm |
| P. F. Anderson @pfanderson RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Timothy Craig Allen @TimAllenMDJD Welcome! #cancersm |
| Jose Hernandez @Pharma_Mty RT @theNCI: The National Cancer Institute is here. Thanks for hosting this #cancersm chat on biomarkers! https://t.co/wizc6w6728 |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validat… |
| #LCSM Chat @lcsmchat RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM |
| P. F. Anderson @pfanderson RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| Timothy Craig Allen @TimAllenMDJD RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM |
| #LCSM Chat @lcsmchat RT @pfanderson: @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validat… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance… |
| Vin :-) @vincruze RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i… |
| Bob Steele @steele_bob RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance… |
| هيوني فهد. @HIONE55 RT @TheLizArmy: @TimAllenMDJD T2: For the brain community, our tumors are tested for biomarkers as a way of determining whether our tumor i… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @AshleySumrallMD @HenningWillers Yes! I just tweeted that! LOL Use #cancersm for tonight's chat. ;) |
 | Brave Bosom @BraveBosom RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| Liz Salmi @TheLizArmy RT @AshleySumrallMD: @TheLizArmy @HenningWillers T1: And it changed in 2016 as the WHO reclassified gliomas #btsm #cancersm https://t.co/gc… |
| Dennis Keim @denniskeim RT @HenningWillers: @stales @drjainsp T2 there can also be normal tissue biomarkers (eg for toxicity predictions) #cancersm |
| Christina Lizaso @btrfly12 T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells – An updated review https://t.co/Lo7npjtVOw #cancersm |
| Timothy Craig Allen @TimAllenMDJD T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether or not a patient might respond to a molecular therapy; and prognostic biomarkers help determine the patient’s chances for long-term survival. #cancersm |
| Vin :-) @vincruze RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| Timothy Craig Allen @TimAllenMDJD RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an… |
| Liz Salmi @TheLizArmy RT @AshleySumrallMD: @TheLizArmy @TimAllenMDJD Except there are places that STILL don’t routinely check #MGMT & #IDH in glioma #btsm #cance… |
| Brave Bosom @BraveBosom RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an… |
| National Cancer Institute @theNCI RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| Christina Lizaso @btrfly12 RT @TheLizArmy: @TimAllenMDJD In 2016 @WHO released a NEW classification of CNS tumors (central nervous system) related to "new" knowledge… |
| P. F. Anderson @pfanderson @TheLizArmy @HenningWillers That's amazing. Many folk I know with childhood trauma introduce themselves with their ACE score, but psych professionals I know have trouble believing this happens. I bet the docs are surprised. #CancerSM |
| Christina Lizaso @btrfly12 RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Dennis Keim @denniskeim RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Dee Sparacio @womenofteal #gyncsm |
| Darcy Burbage @DarcyBurbage RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @TheLizArmy @HenningWillers That's amazing. Many folk I know with childhood trauma introduce themselves with their ACE scor… |
| Dennis Keim @denniskeim RT @HenningWillers: @drjainsp T2 interestingly PSA can also be predictive of treatment outcome and also prognostic #cancersm |
| Timothy Craig Allen @TimAllenMDJD T3: What treatment options can be identified through biomarker testing? #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| Dennis Keim @denniskeim RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L |
| Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| Dee Sparacio @womenofteal #gyncsm |
| Liz Salmi @TheLizArmy Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing... which is absolutely CRUCIAL to our treatment. #BTSM #cancersm |
| #LCSM Chat @lcsmchat RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an… |
| #LCSM Chat @lcsmchat RT @pfanderson: @TheLizArmy @HenningWillers That's amazing. Many folk I know with childhood trauma introduce themselves with their ACE scor… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher #MMSM Biomarkers |
| P. F. Anderson @pfanderson RT @btrfly12: T2: Here's an overview of what is being studied for #ovariancancer Diagnostic and Prognostic Biomarkers in ovarian cancer an… |
| Dee Sparacio @womenofteal RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm |
| Liz Salmi @TheLizArmy RT @TimAllenMDJD: Already needs to be updated. Our understanding of cancer biomarkers is evolving fast! #cancersm https://t.co/MXre3PKV9L |
| Uppity Cancer Pt @UppityCancerP RT @pfanderson: Salivary Biomarkers: Toward Future Clinical and Diagnostic Utilities https://t.co/Q4bzv0UQoc Salivary biomarkers and proteo… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..… |
| National Cancer Institute @theNCI T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in common use: https://t.co/NtPLX1lStR #cancersm |
| Henning Willers, MD @HenningWillers RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| #LCSM Chat @lcsmchat RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..… |
| Pub Health Monitor @monitor_PH RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| Uppity Cancer Pt @UppityCancerP RT @israhkhan: #CANCERSM While the traditional breast carcinoma prognostic markers ER, PR, Her 2 neu predicts whether a patient will need h… |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm |
| Christina Lizaso @btrfly12 RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
 | Med Peds Hospitalist @medpedshosp RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| #LCSM Chat @lcsmchat RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| Brave Bosom @BraveBosom Hi! Taking a break from vacation to say hello TY for organizing this combined chat. I am here from #BRCA community 👏 #cancersm. |
| Dennis Keim @denniskeim RT @womenofteal: @drjainsp And CA-125 is used as a biomarker to measure response to treatment for many women with #ovca #gyncsm #CANCERSM |
| Janet Freeman-Daily @JFreemanDaily RT @pfanderson: @JFreemanDaily @theNCI Even breath! >> VOC breath biomarkers in lung cancer (2016) https://t.co/TmvUTPyxkp Blinded Validat… |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is controversial) #btsm #cancersm |
| Uppity Cancer Pt @UppityCancerP RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T3: What treatment options can be identified through biomarker testing? #cancersm |
| National Cancer Institute @theNCI T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determine whether treatment with hormone therapy or some targeted therapies is appropriate. #CancerSM |
| P. F. Anderson @pfanderson RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| Matthew Katz, MD @subatomicdoc RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| Pub Health Monitor @monitor_PH RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr… |
| Timothy Craig Allen @TimAllenMDJD RT @BraveBosom: Hi! Taking a break from vacation to say hello TY for organizing this combined chat. I am here from #BRCA community 👏 #can… |
| Liz Salmi @TheLizArmy RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr… |
 | spartychemist @spartychemist Biomarkers are indicators that are used to predict or diagnose condition.. in blood cancer patients .presence of certain dna or rna in blood |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin… |
| National Cancer Institute @theNCI T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment and estimate prognosis. #cancersm #lcsm |
 | α¢нмα∂ нαη∂σкσ | hand @achmadhandoko RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin… |
| Pub Health Monitor @monitor_PH RT @theNCI: T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment an… |
| Dee Sparacio @womenofteal #gyncsm |
| P. F. Anderson @pfanderson @TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #CancerSM |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment an… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #MMSM #CancerSM |
| #LCSM Chat @lcsmchat RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin… |
 | Kim Moran-MacIntosh 🇨🇦 @Kamacintosh RT @JFreemanDaily: @theNCI There are also tumor markers in certain bodily fluids other than blood -- for #lungcancer patients, pleural flui… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| #LCSM Chat @lcsmchat RT @theNCI: T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment an… |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #C… |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: @TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #M… |
| Bob Steele @steele_bob Glad to report Wife has final infusion sched 7/22. But dx'd Mon with new side effect: cornea thinning. Hadn't heard of that one. #cancersm |
| Henning Willers, MD @HenningWillers T3 in lung cancer oncogenic alterations in EGFR ALK ROS1 RET et cetera determine treatment choicces #lcsm #cancersm |
| P. F. Anderson @pfanderson RT @theNCI: T3 In breast cancer, testing tumors for estrogen and progesterone receptors and the HER2 protein can help doctors help determin… |
| P. F. Anderson @pfanderson RT @theNCI: T3 In non-small cell lung cancer, an analysis of mutations in the EGFR gene can help doctors determine a patient’s treatment an… |
| Dee Sparacio @womenofteal @pfanderson @TimAllenMDJD great question. #cancersm |
 | c0nc0rdance @c0nc0rdance #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in, the participants are doing a great job of making cancer diagnostics accessible to anyone. Love that scientists/clinicians do this kind of outreach. |
| Dennis Keim @denniskeim Greetings. Checking in bit late too but catching up. Another #bcsm peep. Interesting chat tonight. #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #canc… |
| National Cancer Institute @theNCI T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #immunotherapy drug called an immune checkpoint inhibitor is appropriate. #cancersm https://t.co/n66X2nteXz |
| #LCSM Chat @lcsmchat RT @pfanderson: @TimAllenMDJD I'm curious about the balance between biomarkers and genome for informing treatment decisions and planning #C… |
| Pub Health Monitor @monitor_PH RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: @TimAllenMDJD Can prognostic biomarkers be a group of biomarkers that stratify for risk instead of just 1 biomarker? #M… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TimAllenMDJD T3: identifying #NTRK fusion in #glioma (est 1% of gliomas) opens up avenues for 2 therapies #btsm #canc… |
 | Laronica Conway @louisianagirl91 Great collaboration!!! 👍🏾 #LCSM #CANCERSM |
| #LCSM Chat @lcsmchat RT @steele_bob: Glad to report Wife has final infusion sched 7/22. But dx'd Mon with new side effect: cornea thinning. Hadn't heard of that… |
| Matthew Katz, MD @subatomicdoc RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr… |
| α¢нмα∂ нαη∂σкσ | hand @achmadhandoko RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| #LCSM Chat @lcsmchat RT @HenningWillers: T3 in lung cancer oncogenic alterations in EGFR ALK ROS1 RET et cetera determine treatment choicces #lcsm #cancersm |
| Israh (K.)Akhtar @israhkhan #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for colo-rectal Ca, HCG for choriocarcinoma |
| Henning Willers, MD @HenningWillers T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #cancersm |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TimAllenMDJD T3: and... finding #H3K27m mutations opens the door to try drugs like #ONC201 (as seen at #ASCO19) #cancersm |
 | LIU Dawei @liudawei05329 RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM |
| Bob Steele @steele_bob RT @louisianagirl91: Great collaboration!!! 👍🏾 #LCSM #CANCERSM https://t.co/WYiLZac5bP |
| #LCSM Chat @lcsmchat RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,… |
| Henning Willers, MD @HenningWillers RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Liz Salmi @TheLizArmy @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of standard of care. In 2016, I asked my neuro-onc to run my tissue for the biomarkers panel. He asked, "Why would you want to know what your biomarkers are?" #btsm #cancersm https://t.co/BGY4SHbgDn |
| Timothy Craig Allen @TimAllenMDJD My best to your wife. #cancersm |
| Jamie Holloway, PhD @jamienholloway T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, antibodies like herceptin... They can also point to clinical trials #cancersm |
| Dee Sparacio @womenofteal #gyncsm |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: @spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TimAllenMDJD T3: and... finding #H3K27m mutations opens the door to try drugs like #ONC201 (as seen at #ASCO19) #canc… |
| P. F. Anderson @pfanderson @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about the rare miracles, but ... there are a lot of non-miracles, and it's still really new. #CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #c… |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col… |
| Janet Freeman-Daily @JFreemanDaily @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat resistance to targeted therapies. #LCSM #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @louisianagirl91: Great collaboration!!! 👍🏾 #LCSM #CANCERSM https://t.co/WYiLZac5bP |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Brave Bosom @BraveBosom @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for better biomarkers in the future for #brca. #cancersm |
| Laronica Conway @louisianagirl91 👋🏾👋🏾 Hey Dr. Tim! Late and lurking! 👀 🤗 #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @denniskeim: Greetings. Checking in bit late too but catching up. Another #bcsm peep. Interesting chat tonight. #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,… |
| #LCSM Chat @lcsmchat RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Timothy Craig Allen @TimAllenMDJD RT @womenofteal: @pfanderson @TimAllenMDJD great question. #cancersm |
| Dee Sparacio @womenofteal RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col… |
| P. F. Anderson @pfanderson RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: T3 in lung cancer oncogenic alterations in EGFR ALK ROS1 RET et cetera determine treatment choicces #lcsm #cancersm |
| Liz Salmi @TheLizArmy RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,… |
| National Cancer Institute @theNCI RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re… |
| Darcy Burbage @DarcyBurbage RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col… |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re… |
| P. F. Anderson @pfanderson RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th… |
| #LCSM Chat @lcsmchat RT @israhkhan: #cancersm Other well known diagnostic biomarkers are AFP for hepatocellular carcinoma, CA19-9 for pancreatic Ca, CEA for col… |
| c0nc0rdance @c0nc0rdance RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Timothy Craig Allen @TimAllenMDJD T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #cancersm |
| #LCSM Chat @lcsmchat RT @HenningWillers: T3 often overlooked, in #radonc tumor size/volume determines radiation dose and whether chemotherapy should be added #c… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TimAllenMDJD T3: and... finding #H3K27m mutations opens the door to try drugs like #ONC201 (as seen at #ASCO19) #canc… |
| Henning Willers, MD @HenningWillers RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: @spartychemist Thanks. So my m-spike is a biomarker of my cancer. #MMSM #cancerSM |
| Brave Bosom @BraveBosom RT @UppityCancerP: Hey, all. Meet @stales. She is the health social media goddess from #bcsm and will keep all of us on track. You may borr… |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan… |
 | Natick Bobcat @NatickBobCat RT @TimAllenMDJD: Welcome to #cancersm Chat! This hour all the cancer hashtag communities come together to visit, learn, & share perspectiv… |
| Timothy Craig Allen @TimAllenMDJD RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a… |
| #LCSM Chat @lcsmchat RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan… |
| α¢нмα∂ нαη∂σкσ | hand @achmadhandoko RT @theNCI: T2 Tumor tissue markers, which are found in actual tumors, are used to diagnose, stage, and/or classify cancer, to estimate pro… |
| #LCSM Chat @lcsmchat RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @theNCI Analysis of mutations in EGFR+ NSCLC (and other oncogene-driven cancers) can also help determine how to treat re… |
| Christina Lizaso @btrfly12 @steele_bob We were just hearing about eye-related side effects on last night's #gyncsm chat about maintenance therapies. #cancersm |
| α¢нмα∂ нαη∂σкσ | hand @achmadhandoko RT @theNCI: T2 Circulating tumor markers, which can be found in the blood, urine, stool, or other bodily fluids of some patients with cance… |
| #LCSM Chat @lcsmchat RT @BraveBosom: @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for bet… |
| Israh (K.)Akhtar @israhkhan #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive |
| c0nc0rdance @c0nc0rdance RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| α¢нмα∂ нαη∂σкσ | hand @achmadhandoko RT @theNCI: T2 There are two main types of tumor markers that have different uses in cancer care: circulating tumor markers and tumor tissu… |
| Christina Lizaso @btrfly12 RT @c0nc0rdance: #CancerSM is a Twitter chat discussing the basics of biomarker testing for cancer. If it's a topic you're interested in,… |
| #LCSM Chat @lcsmchat RT @btrfly12: @steele_bob We were just hearing about eye-related side effects on last night's #gyncsm chat about maintenance therapies. #ca… |
 | eduardo cervera @emircervera RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive |
| Timothy Craig Allen @TimAllenMDJD Howdy, @louisianagirl91! Glad you're here at #cancersm |
| c0nc0rdance @c0nc0rdance RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| National Cancer Institute @theNCI RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| Dennis Keim @denniskeim RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive |
 | We Dietitians @WeDietitians RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..… |
| Timothy Craig Allen @TimAllenMDJD RT @btrfly12: @steele_bob We were just hearing about eye-related side effects on last night's #gyncsm chat about maintenance therapies. #ca… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| Timothy Craig Allen @TimAllenMDJD RT @BraveBosom: @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for bet… |
| Dennis Keim @denniskeim RT @MyelomaTeacher: @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM |
| Henning Willers, MD @HenningWillers T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as we keep testing & building data. #btsm #hncsm #thycsm #cancersm https://t.co/KV6Ct0nXaS |
 | David Veyna @DavidVeyna RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
 | Frufruit @_lulyf RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: @theNCI In myeloma the expression of BCMA is used as a biomarker for CAR-T cell therapy #MMSM #cancerSM |
| Liz Salmi @TheLizArmy @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #cancersm |
| P. F. Anderson @pfanderson @BraveBosom @womenofteal @drjainsp Agree! That's one of the messy ones (CA125), and that it is so inconsistent directly connects with lack of testing and unwillingness to pursue costly invasive explorations for #OvCa and some other #GynCSM #CancerSM |
| Dee Sparacio @womenofteal @BraveBosom @drjainsp Yes we need a better biomarker or set of biomarkers to screen for OC. It is not a good marker for me either . #gyncsm #cancersm |
| Jamie Holloway, PhD @jamienholloway RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w… |
| #LCSM Chat @lcsmchat RT @HenningWillers: T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| Christina Lizaso @btrfly12 RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan… |
| #LCSM Chat @lcsmchat RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can… |
| Liz Salmi @TheLizArmy @btrfly12 @steele_bob EYE-RELATED SIDE EFFECTS? Wow. #cancersm |
| Janet Freeman-Daily @JFreemanDaily Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tested for EGFR (despite having FDA-approved treatments). % for other NSCLC genomic drivers is even less. Frustrating! #LCSM #cancersm |
| #LCSM Chat @lcsmchat RT @pfanderson: @BraveBosom @womenofteal @drjainsp Agree! That's one of the messy ones (CA125), and that it is so inconsistent directly con… |
| Christina Lizaso @btrfly12 RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a… |
| Timothy Craig Allen @TimAllenMDJD RT @womenofteal: @BraveBosom @drjainsp Yes we need a better biomarker or set of biomarkers to screen for OC. It is not a good marker for m… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @BraveBosom @womenofteal @drjainsp Agree! That's one of the messy ones (CA125), and that it is so inconsistent directly con… |
| Uppity Cancer Pt @UppityCancerP Molecular testing needs to be standard of care. New oncologist just suggested this. When diagnosed in 2012, not an option #cancersm |
| Bob Steele @steele_bob RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can… |
| Brave Bosom @BraveBosom RT @womenofteal: @BraveBosom @drjainsp Yes we need a better biomarker or set of biomarkers to screen for OC. It is not a good marker for m… |
| Sarika Jain @drjainsp RT @israhkhan: #CANCERSM advanced lung cancer patients may be responsive to immunotherapy (keytruda)if the tumor cells are PDL1 positive |
| P. F. Anderson @pfanderson RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w… |
 | Sabin Motwani @sabinbmotwanimd Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Christina Lizaso @btrfly12 RT @BraveBosom: @womenofteal @drjainsp CA125 has a ton of false positives/ can be inaccurate. I have had quite a few scares. Hope for bet… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| Dee Sparacio @womenofteal RT @TheLizArmy: @TimAllenMDJD Would it be fair to say "biomarkers are the new pathology?" Or is it a teamwork between the two? #btsm #can… |
| Betsy @wildwestannie RT @pfanderson: @womenofteal @TimAllenMDJD We hear a lot these days about analyzing tumor genomes for resistant cases, and we hear about th… |
| Timothy Craig Allen @TimAllenMDJD Fair enough! #cancersm |
| Brave Bosom @BraveBosom RT @pfanderson: @BraveBosom @womenofteal @drjainsp Agree! That's one of the messy ones (CA125), and that it is so inconsistent directly con… |
| #LCSM Chat @lcsmchat RT @UppityCancerP: Molecular testing needs to be standard of care. New oncologist just suggested this. When diagnosed in 2012, not an optio… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w… |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: T3 are there any biomarkers that determine choice of surgery, for or against ? #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @UppityCancerP: Molecular testing needs to be standard of care. New oncologist just suggested this. When diagnosed in 2012, not an optio… |
| #LCSM Chat @lcsmchat RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Bob Steele @steele_bob RT @UppityCancerP: Molecular testing needs to be standard of care. New oncologist just suggested this. When diagnosed in 2012, not an optio… |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| Matthew Katz, MD @subatomicdoc @HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @btrfly12 @steele_bob EYE-RELATED SIDE EFFECTS? Wow. #cancersm |
| Timothy Craig Allen @TimAllenMDJD T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patient might benefit from treatment with the corresponding drug. This is personalized medicine! #cancersm |
| Jamie Holloway, PhD @jamienholloway Excellent point! It's just as important to know what drugs *won't* work! #cancersm |
| Henning Willers, MD @HenningWillers RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| #LCSM Chat @lcsmchat RT @subatomicdoc: @HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm |
| Christina Lizaso @btrfly12 RT @AshleySumrallMD: @TimAllenMDJD T3: I love this paper outlining tumor types affected by #NTRK fusion. I think we will see even more as w… |
 | Amy H. Deeken @AmyHDeekenMD RT @TimAllenMDJD: T3: Therapeutic molecular biomarker tests identify a therapeutic target for which there is a currently available drug. #… |
| Liz Salmi @TheLizArmy RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| Dennis Keim @denniskeim RT @subatomicdoc: @HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
 | Dr. Gina Merchant @DrGMerchant RT @theNCI: T1 Tumor markers provide information about a cancer, such as how aggressive it is, whether it can be treated with a targeted th… |
| Timothy Craig Allen @TimAllenMDJD RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| Dennis Keim @denniskeim RT @UppityCancerP: Molecular testing needs to be standard of care. New oncologist just suggested this. When diagnosed in 2012, not an optio… |
| #LCSM Chat @lcsmchat RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| Timothy Craig Allen @TimAllenMDJD RT @subatomicdoc: @HenningWillers Do chromogranin/synaptophysin count to help in lung cancer? #cancersm |
| Darcy Burbage @DarcyBurbage RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| Dee Sparacio @womenofteal RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| National Cancer Institute @theNCI RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| Dennis Keim @denniskeim RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Sarika Jain @drjainsp T3: On the other hand, if a patient's biomarker testing does not show that that patient's cancer contains that therapeutic target on the cancer cell, then treating that patient with the corresponding, often expensive drug would provide no therapeutic benefit. #cancersm |
| Dee Sparacio @womenofteal RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| Henning Willers, MD @HenningWillers @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these mutations #cancersm #lcsm |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| Christina Lizaso @btrfly12 RT @JFreemanDaily: Though biomarker testing is in @NCCN guidelines for NSCLC, recent estimates say at most 60% of eligible patients are tes… |
| Timothy Craig Allen @TimAllenMDJD T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
| Darcy Burbage @DarcyBurbage RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| Matthew Steliga MD @SteligaMD RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| Sarika Jain @drjainsp T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with these molecular therapies if the biomarker testing shows that the drug would not benefit the patient. #cancersm |
| Dee Sparacio @womenofteal RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
 | Said Bahwal @saidbahwal #cancersm new hashtag chat to discuss about tumor biomarkers. |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancersm (current ex: melanoma) |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these… |
| Bob Steele @steele_bob RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T3: On the other hand, if a patient's biomarker testing does not show that that patient's cancer contains that therapeutic ta… |
| #LCSM Chat @lcsmchat RT @drjainsp: T3: On the other hand, if a patient's biomarker testing does not show that that patient's cancer contains that therapeutic ta… |
| #LCSM Chat @lcsmchat RT @HenningWillers: @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these… |
 | ﺍﻣﻴﺮ ﺍﻟﺬﻛﺮ @AmirulZickery RT @jamienholloway: T2: In cancer, biomarker testing is analysis of DNA, RNA, or proteins that provide info about the diagnosis, prognosis,… |
| National Cancer Institute @theNCI RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
| #LCSM Chat @lcsmchat RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| Timothy Craig Allen @TimAllenMDJD RT @saidbahwal: #cancersm new hashtag chat to discuss about tumor biomarkers. |
 | cunmarket.com @ebscbwi RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Jamie Holloway, PhD @jamienholloway I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker expression than tumor histology. #cancersm |
| Matthew Katz, MD @subatomicdoc RT @HenningWillers: @JFreemanDaily @NCCN T3 moreover #lungcancer patients with non-metastatic disease are even less often tested for these… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancers… |
| Amy H. Deeken @AmyHDeekenMD RT @TimAllenMDJD: T2: Diagnostic biomarkers help in the diagnosis of the cancer itself; therapeutic biomarkers help in determining whether… |
| ﺍﻣﻴﺮ ﺍﻟﺬﻛﺮ @AmirulZickery RT @theNCI: T2 If you are interested in learning more about tumor markers, please see our expert-reviewed fact sheet on these biomarkers: h… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @HenningWillers @TimAllenMDJD In the future, I hope we have this to help w managing various #brainmets #btsm #cancers… |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| Henning Willers, MD @HenningWillers @subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm |
| #LCSM Chat @lcsmchat RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex… |
 | Amanda Haddock 🧬 @AmandaHaddock Checking in late but trying to catch up. Coming in from #btsm community.#CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex… |
| Dennis Keim @denniskeim RT @TheLizArmy: @HenningWillers T1: In the brain tumor community, biomarkers are how we patients introduce ourselves to each other. No lon… |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
| Dennis Keim @denniskeim RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Amanda Haddock 🧬 @AmandaHaddock RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| Christina Lizaso @btrfly12 RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| #LCSM Chat @lcsmchat RT @HenningWillers: @subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm |
| Amy H. Deeken @AmyHDeekenMD RT @TimAllenMDJD: T2: Molecular biomarker testing involves laboratory tests that evaluate and identify the presence, on the surface of a c… |
| P. F. Anderson @pfanderson @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything in the body. Sometimes treatments exacerbate underlying problems. They've known about eyes a long time > Ocular toxicity of antineoplastic agents. (1983) https://t.co/vhqn7tU9PU #CancerSM |
| Sarika Jain @drjainsp T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #cancersm |
| Dennis Keim @denniskeim RT @TheLizArmy: Great point! People facing a brain tumor--if diagnosed at a community hospital--might not be told about biomarker testing..… |
| Janet Freeman-Daily @JFreemanDaily @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer. Biomarkers are not yet useful in small cell lung cancer, except for clinical trial enrollment. #LCSM #cancersm |
| Laronica Conway @louisianagirl91 RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T3: If the molecular biomarker testing shows that the patient's cancer contains the therapeutic target, then that patien… |
| Bob Steele @steele_bob RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc… |
| #LCSM Chat @lcsmchat RT @pfanderson: @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything… |
| Israh (K.)Akhtar @israhkhan #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder carcinoma and like EGFR is a tyrosine kinase receptor gene |
| Christina Lizaso @btrfly12 RT @jamienholloway: I wouldn't go quite that far, but there are increasingly more treatment options that are more dependent on biomarker ex… |
| Matthew Katz, MD @subatomicdoc RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
| Dennis Keim @denniskeim RT @jamienholloway: T3: SO MANY OPTIONS can be identified through biomarkers. Hormone therapy, immunotherapy, targeted kinase inhibitors, a… |
 | njbmd @njbmd RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.… |
| Darcy Burbage @DarcyBurbage RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything… |
| Bob Steele @steele_bob RT @israhkhan: #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder c… |
| Timothy Craig Allen @TimAllenMDJD RT @AmandaHaddock: Checking in late but trying to catch up. Coming in from #btsm community.#CancerSM |
| Timothy Craig Allen @TimAllenMDJD RT @HenningWillers: @subatomicdoc T3 good one, small cell cancer by IHC stains would make choice against surgery #lcsm #cancersm |
| #LCSM Chat @lcsmchat RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc… |
| Dennis Keim @denniskeim RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD I was diagnosed with a brain tumor in 2008 when checking for biomarkers was not part of stan… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @TheLizArmy @TimAllenMDJD Pathology in #lungcancer still requires immunohistochemistry to determine type of lung cancer.… |
| Janet Freeman-Daily @JFreemanDaily @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is possible. #LCSM #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder c… |
| P. F. Anderson @pfanderson @TimAllenMDJD Well said! We need a nice little cartoon or comic to illustrate this concept. A good visual #CancerSM |
| #LCSM Chat @lcsmchat RT @israhkhan: #CANCERSM more recently Fibroblast growth factor receptor 3 (FGFR3) mutations have been seen to occur in low grade bladder c… |
 | Julie Bonnett @Brjukala YES!!!!!!!! So patients done endure treatments that WON’T work! Just as important as pre-selecting therapy they are likely to respond to!! |
| Timothy Craig Allen @TimAllenMDJD T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cells or cancer cell DNA or RNA that is floating in the blood stream. #cancersm |
| P. F. Anderson @pfanderson RT @jamienholloway: Excellent point! It's just as important to know what drugs *won't* work! #cancersm https://t.co/ozpQTMRriS |
| P. F. Anderson @pfanderson RT @sabinbmotwanimd: Also important not only to find therapeutic biomarkers but also markers of resistance #cancersm |
| Dee Sparacio @womenofteal #gyncsm |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T4: What biomarker tests should be run for which types of cancers? What is a liquid biopsy and when is useful? #cancersm |
| Sarika Jain @drjainsp T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS genes for rearrangements. Many pathologists examine other more recently recognized mutations. #cancersm |
| Amanda Haddock 🧬 @AmandaHaddock RT @AshleySumrallMD: @TimAllenMDJD T3 In #glioma, we use biomarkers as part of trial eligibilty. For ex: #MGMT status (although it is contr… |
| Dennis Keim @denniskeim RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Timothy Craig Allen @TimAllenMDJD RT @pfanderson: @TimAllenMDJD Well said! We need a nice little cartoon or comic to illustrate this concept. A good visual #CancerSM |
| National Cancer Institute @theNCI T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood or for pieces of DNA from tumor cells that are in the blood. #cancersm https://t.co/Qp4ziTm1ad |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is pos… |
| Pub Health Monitor @monitor_PH RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| P. F. Anderson @pfanderson RT @drjainsp: T3 These drugs, like all drugs, have side effects, so beyond the needless cost, it is important to not treat patients with th… |
| Dennis Keim @denniskeim RT @theNCI: T1 A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular m… |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @jamienholloway Depends on tumor type. Look at how “breast ca” is a multitude of diseases defined by ER, PR, H2N, and now PIK3CA. #bcsm #cancersm |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @HenningWillers Technically speaking, CT and PET scans are biomarkers. They would help determine whether surgery is pos… |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS ge… |
| P. F. Anderson @pfanderson RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell… |
| National Cancer Institute @theNCI RT @drjainsp: T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS ge… |
 | José Gaxiola-López @GAXILO RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| P. F. Anderson @pfanderson RT @drjainsp: T4 There are guidelines for what biomarker testing must be performed on different cancer types. https://t.co/0NmT5EaL4E #canc… |
| Bob Steele @steele_bob RT @pfanderson: @TheLizArmy @btrfly12 @steele_bob I wonder sometimes about general role of inflammation, which targets just about anything… |
| #LCSM Chat @lcsmchat RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell… |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| #LCSM Chat @lcsmchat RT @drjainsp: T4 For lung cancers, the minimum testing that must be performed is to look at the EGFR gene for mutations and ALK1 and ROS ge… |
| Amanda Haddock 🧬 @AmandaHaddock @theNCI Thanks for this!! Was just wondering if something like this existed!#cancersm |
| National Cancer Institute @theNCI T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm |
| Sarika Jain @drjainsp T4 For colon cancers, RAS gene testing to guide anti-EGFR therapy. BRAF mutational testing should also be performed for prognostic information. #cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| Pub Health Monitor @monitor_PH RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @jamienholloway Depends on tumor type. Look at how “breast ca” is a multitude of diseases defined by ER, PR, H2N, and… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @jamienholloway Depends on tumor type. Look at how “breast ca” is a multitude of diseases defined by ER, PR, H2N, and… |
| Darcy Burbage @DarcyBurbage RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell… |
 | jaime rueda @ruedaj2003 RT @JFreemanDaily: Many non-small cell #lungcancer people also identify with biomarkers--EGFR, ALK, ROS1, BRAF, NTRK, KRAS, RET .... #LCSM… |
| Henning Willers, MD @HenningWillers RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| Christina Lizaso @btrfly12 RT @TimAllenMDJD: T4: "Liquid biopsy" refers to molecular biomarker testing performed not on a patient's cancer tissue, but on cancer cell… |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T4 For colon cancers, RAS gene testing to guide anti-EGFR therapy. BRAF mutational testing should also be performed for progn… |
| Timothy Craig Allen @TimAllenMDJD RT @AmandaHaddock: @theNCI Thanks for this!! Was just wondering if something like this existed!#cancersm |
| #LCSM Chat @lcsmchat RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T4 A #liquidbiopsy may be used to help find cancer at an early stage. #cancersm |
| Louella Vasquez @VasquezLouella RT @theNCI: T3 A number of tumor markers are currently being used for a wide range of cancer types. Here’s a list of tumor markers in commo… |
| Darcy Burbage @DarcyBurbage RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| #LCSM Chat @lcsmchat RT @drjainsp: T4 For colon cancers, RAS gene testing to guide anti-EGFR therapy. BRAF mutational testing should also be performed for progn… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher @TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy especially for repeat MRD testing. #CancerSM #MMSM |
| Liz Salmi @TheLizArmy @AshleySumrallMD @TimAllenMDJD We could do a whole session on this at @NeuroOnc. 😞#SNO2019 #cancersm #btsm |
| Sarika Jain @drjainsp T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohistochemistry. #cancersm |
| Janet Freeman-Daily @JFreemanDaily @HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #LCSM #cancersm |
| Amanda Haddock 🧬 @AmandaHaddock I get asked about different tumor markers all the time. Bookmarking this list! |
| National Cancer Institute @theNCI T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come back. Taking multiple samples of blood over time may also reveal the molecular changes taking place in a tumor. #cancersm #liquidbiopsy https://t.co/gaBX0Qvr3H |
| Pub Health Monitor @monitor_PH RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b… |
| Timothy Craig Allen @TimAllenMDJD RT @MyelomaTeacher: @TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy… |
 | Ivan Womboldt @iwomboldt RT @theNCI: T3 In many types of cancer, seeing whether the tumor makes the PD-L1 protein can determine whether treatment with a type of #im… |
| Timothy Craig Allen @TimAllenMDJD RT @TheLizArmy: @AshleySumrallMD @TimAllenMDJD We could do a whole session on this at @NeuroOnc. 😞#SNO2019 #cancersm #btsm |
| Ashley Love Sumrall, MD, FACP @AshleySumrallMD @TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz |
 | Eden Lake @EdenLake RT @israhkhan: #CANCERSM- These are the various faces of this deadly disease a) breast cancer in bone b) hepatocellular carcinoma in asciti… |
| @MyelomaTeacher - Cindy Chmielewski @MyelomaTeacher RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| P. F. Anderson @pfanderson RT @theNCI: T4 A #liquidbiopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in the blood… |
| Timothy Craig Allen @TimAllenMDJD RT @JFreemanDaily: @HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #L… |
| Timothy Craig Allen @TimAllenMDJD RT @drjainsp: T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohisto… |
| Israh (K.)Akhtar @israhkhan #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung (small cell carcinoma ) https://t.co/EtuD0NG1Ni |
| Timothy Craig Allen @TimAllenMDJD RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b… |
| #LCSM Chat @lcsmchat RT @MyelomaTeacher: @TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy… |
| #LCSM Chat @lcsmchat RT @drjainsp: T4 For Breast cancers, the pathologist performs testing for estrogen receptor, progesterone receptor, and HER2 by immunohisto… |
| #LCSM Chat @lcsmchat RT @JFreemanDaily: @HenningWillers @subatomicdoc Not necessarily--surgery is still an option for some SCLC patients per NCCN guidelines. #L… |
| #LCSM Chat @lcsmchat RT @theNCI: T4 A liquid biopsy may also be used to help plan treatment or to find out how well treatment is working or if cancer has come b… |
| Timothy Craig Allen @TimAllenMDJD RT @AshleySumrallMD: @TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz |
| Eden Lake @EdenLake Late (damn work) but here! #cancersm #lcsm |
| Timothy Craig Allen @TimAllenMDJD RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung… |
| #LCSM Chat @lcsmchat RT @AshleySumrallMD: @TimAllenMDJD Or CSF! T4 #btsm #cancersm https://t.co/4iKmHHEJXz |
| #LCSM Chat @lcsmchat RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung… |
| National Cancer Institute @theNCI T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https://t.co/zuL4GnA0CV #liquidbiopsy #cancersm |
| Peggy Dennis @peggyddennis T4 Why stop on a just a few or only those actionable?Check all possible so as treatments become available new biopsy is not need. #cancersm |
| Pub Health Monitor @monitor_PH RT @theNCI: T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https:… |
| P. F. Anderson @pfanderson @theNCI It's pretty amazing these days what can be done with "it's just a blood test" #CancerSM |
| Timothy Craig Allen @TimAllenMDJD T4: Liquid biopsy is used in cases where a biopsy of a patient's cancer cannot be performed because the patient is too ill to tolerate the diagnostic procedure, or where the cancer site is difficult to access with a biopsy e.g., a lesion deep inside the body. #cancersm |
 | Andrea @ahobby9 RT @saidbahwal: #cancersm new hashtag chat to discuss about tumor biomarkers. |
| Christina Lizaso @btrfly12 RT @MyelomaTeacher: @TimAllenMDJD In myeloma it would be great to have a liquid biopsy available instead of the painful bone marrow biopsy… |
| P. F. Anderson @pfanderson RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung… |
| Bob Steele @steele_bob RT @israhkhan: #CANCERSM sadly not much is known about the genetics, biomarkers or prognostic indicators of this deadly cancer of the lung… |
 | Bora Lim, MD @naborala RT @theNCI: T4 From NCI’s Cancer Currents blog last year: Liquid biopsy may predict the risk of breast cancer returning years later: https:… |